Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by High-Resolution Mass Spectrometry

Authors

DOI:

https://doi.org/10.21627/2xkas668

Keywords:

Cushing’s syndrome , iatrogenic glucocorticoid exposure, dietary supplement adulteration, dexamethasone, untargeted high-resolution mass spectrometry, clinical toxicology, adrenal insufficiency, undeclared pharmaceuticals

Downloads

Published

2026-08-21

Issue

Vol. 39 No. 1 (2026)

Section

Case Report

License

Copyright (c) 2026 The Author(s). Published by JMSACL (Journal of Mass Spectrometry and Advances in the Clinical Lab). Licensed under CC BY.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

How to Cite

1.
Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by High-Resolution Mass Spectrometry. J Mass Spectrom Adv Clin Lab [Internet]. 2026 Aug. 21 [cited 2026 Sep. 11];39(1). Available from: https://rel.journals.sup.org/index.php/jmsacl/article/view/104